NEWS: Lyme culture test causes uproar

30th January 2013


Medscape Today looks into the controversy surrounding the new Borrelia culture test by Advanced Laboratory Services.

From Medscape Today news, Jan. 30, 2013:

By Janis C. Kelly

A new chapter in the Lyme disease controversy opened in September 2011 when Advanced Laboratory Services, Inc, announced the commercial availability of a new culture test for Borrelia burgdorferi. Some Lyme patient advocacy groups and physicians began encouraging patients to have the $595 test, but others are concerned about the early commercialization of the still-unvalidated test. This concern may result in changes to how the US Food and Drug Administration (FDA) regulates so-called “homebrew” or laboratory-developed tests (LDTs).

Physicians on all sides of the Lyme disease arena agree that a reliable culture test for active Borrelia infection would be a breakthrough. They differ on whether it is a good idea to market a blood test to consumers before it has been validated, peer-reviewed, published, reviewed by the FDA, or widely vetted by infectious disease experts with experience in Borrelia infections.

Click here to read the rest of the article.


Post your comment

Please limit responses to 150 words. (And please, no vulgar language, no personal attacks, no spam.) Comments are moderated, so there may be a delay before they appear on website.

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>